Replies to post #4262 on Antares Pharma, Inc. (ATRS)

[Frauddoc]

Thanks Ryman, I have spoken with I.R. about the 30 million share offering deal with Cowen. I asked if any of those shares had been sold into the market yet and he stated they were not required to disclose when that takes place. They would only have to disclose it after the fact at the next quarterly earnings. I can see why they would not want that information public as it may cause the stock to sell off. Unfortunately ATRS has had a series of delays over the last several years and I am hopeful they can pull these approvals and launches off without any major issues.